臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"ann lii cheng"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 226-250 / 690 (共28页)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-09-01T01:54:23Z	Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival	Shen Y.-C.; Hu F.-C.; Jeng Y.-M.; Chang Y.-T.; Lin Z.-Z.; Chang M.-C.; Hsu C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:23Z	Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: The molecular mechanism and the clinical application	Lee J.-H.; ANN-LII CHENG; Lin C.-W.; Kuo S.-H.
臺大學術典藏	2021-09-01T01:54:22Z	Gastric perforation presenting as empyema in a patient with pancreatic cancer on bevacizumab treatment	Shao Y.-Y.; Lin Z.-Z.; Liang P.-C.; Tien Y.-W.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:22Z	Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway	Chen K.-F.; Yeh P.-Y.; Hsu C.; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:21Z	EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment	Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; ANN-LII CHENG; Yang P.-C.
臺大學術典藏	2021-09-01T01:54:21Z	Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method - Analysis of 2010 Taiwanese patients	Chen C.-H.; Hu F.-C.; Huang G.-T.; Lee P.-H.; Tsang Y.-M.; ANN-LII CHENG; Chen D.-S.; Wang J.-D.; Sheu J.-C.
臺大學術典藏	2021-09-01T01:54:21Z	Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia	Lin C.-H.; Liau J.-Y.; Lu Y.-S.; Huang C.-S.; Lee W.-C.; Kuo K.-T.; Shen Y.-C.; Kuo S.-H.; Lan C.; Liu J.M.; Kuo W.-H.; Chang K.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:20Z	Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study	Faivre S.; Raymond E.; Boucher E.; Douillard J.; Lim H.Y.; Kim J.S.; Zappa M.; Lanzalone S.; Lin X.; DePrimo S.; Harmon C.; Ruiz-Garcia A.; Lechuga M.J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:20Z	Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma	Yang S.-H.; Lin Z.-Z.; Kuo S.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:20Z	Lamivudine and hepatitis B reactivation	Hsu C.; ANN-LII CHENG; Chen P.-J.
臺大學術典藏	2021-09-01T01:54:19Z	Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer	Lin C.-C.; Hsu C.-H.; Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; Huang K.-H.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏	2021-09-01T01:54:19Z	Sorafenib for the treatment of hepatocellular carcinoma across geographic regions	Hsu C.; Shen Y.-C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:19Z	Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma	Ou D.-L.; Shen Y.-C.; Liang J.-D.; Liou J.-Y.; Yu S.-L.; Fan H.-H.; Wang D.-S.; Lu Y.-S.; Hsu C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:19Z	Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast - A review of 42 primary and secondary cases in Taiwanese patients	Lin Y.-C.; Tsai C.-H.; Wu J.-S.; Huang C.-S.; Kuo S.-H.; Lin C.-W.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:18Z	Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy	Lin C.-H.; Lien H.-C.; Hu F.-C.; Lu Y.-S.; Kuo S.-H.; Wu L.-C.; You S.-L.; ANN-LII CHENG; Chang K.-J.; Huang C.-S.
臺大學術典藏	2021-09-01T01:54:18Z	Synergistic Effect of Radiation and Interleukin-6 on Hepatitis B Virus Reactivation in Liver Through STAT3 Signaling Pathway	Chou C.H.; Chen P.-J.; Jeng Y.-M.; ANN-LII CHENG; Huang L.-R.; Cheng J.C.-H.
臺大學術典藏	2021-09-01T01:54:18Z	Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer	Ch'ang H.-J.; Huang C.-L.; Wang H.-P.; Shiah H.-S.; Chang M.-C.; Jan C.-M.; Chen J.-S.; Tien Y.-W.; Hwang T.-L.; Lin J.-T.; ANN-LII CHENG; Whang-Peng J.; Chen L.-T.
臺大學術典藏	2021-09-01T01:54:18Z	Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design	Hsu C.; Shen Y.-C.; Cheng C.-C.; Hu F.-C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:17Z	Molecular targeted therapy for advanced hepatocellular carcinoma: Current status and future perspectives	Shen Y.-C.; Hsu C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:17Z	Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions	Shao Y.-Y.; Hu F.-C.; Liang J.-T.; Chiu W.-T.; ANN-LII CHENG; Yang C.-H.
臺大學術典藏	2021-09-01T01:54:17Z	Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma	Hsu C.-H.; Shen Y.-C.; Lin Z.-Z.; Chen P.-J.; Shao Y.-Y.; Ding Y.-H.; Hsu C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:16Z	Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation	Chen K.-F.; Yu H.-C.; Liu T.-H.; Lee S.-S.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:16Z	Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma	Hsu C.-H.; Yang T.-S.; Hsu C.; Toh H.C.; Epstein R.J.; Hsiao L.-T.; Chen P.-J.; Lin Z.-Z.; Chao T.-Y.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:16Z	Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin	Shao Y.-Y.; Kuo K.-T.; Hu F.-C.; Lu Y.-S.; Huang C.-S.; Liau J.-Y.; Lee W.-C.; Hsu C.; Kuo W.-H.; Chang K.-J.; Lin C.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:16Z	Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma	Omata M.; Lesmana L.A.; Tateishi R.; Chen P.-J.; Lin S.-M.; Yoshida H.; Kudo M.; Lee J.M.; Choi B.I.; Poon R.T.P.; Shiina S.; ANN-LII CHENG; Jia J.-D.; Obi S.; Han K.H.; Jafri W.; Chow P.; Lim S.G.; Chawla Y.K.; Budihusodo U.; Gani R.A.; Lesmana C.R.; Putranto T.A.; Liaw Y.F.; Sarin S.K.

显示项目 226-250 / 690 (共28页)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 51124200 在线人数 : 735 教育部委托研究计画计画执行:国立台湾大学图书馆